DK1131318T3 - Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner - Google Patents

Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner

Info

Publication number
DK1131318T3
DK1131318T3 DK99961578T DK99961578T DK1131318T3 DK 1131318 T3 DK1131318 T3 DK 1131318T3 DK 99961578 T DK99961578 T DK 99961578T DK 99961578 T DK99961578 T DK 99961578T DK 1131318 T3 DK1131318 T3 DK 1131318T3
Authority
DK
Denmark
Prior art keywords
dithietanes
preparation
substituted pyrazoles
substituted
pyrazoles
Prior art date
Application number
DK99961578T
Other languages
English (en)
Inventor
Matthew J Graneto
Susan J Hartmann
Suzanne Metz
John Jeffrey Talley
Michael L Vazquez
David L Brown
Richard M Weier
Michael A Stealey
Xiangdong Xu
Original Assignee
Searle Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle Llc filed Critical Searle Llc
Application granted granted Critical
Publication of DK1131318T3 publication Critical patent/DK1131318T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
DK99961578T 1998-11-20 1999-11-18 Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner DK1131318T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10917798P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
DK1131318T3 true DK1131318T3 (da) 2004-06-01

Family

ID=22326224

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99961578T DK1131318T3 (da) 1998-11-20 1999-11-18 Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner

Country Status (14)

Country Link
US (6) US6143892A (da)
EP (1) EP1131318B1 (da)
JP (1) JP2002530404A (da)
AT (1) ATE262523T1 (da)
AU (1) AU758811B2 (da)
CA (1) CA2350081A1 (da)
DE (1) DE69915862T2 (da)
DK (1) DK1131318T3 (da)
ES (1) ES2219092T3 (da)
IL (1) IL142999A0 (da)
NZ (1) NZ511594A (da)
PT (1) PT1131318E (da)
WO (1) WO2000031072A1 (da)
ZA (1) ZA200103759B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979686B1 (en) 2001-12-07 2005-12-27 Pharmacia Corporation Substituted pyrazoles as p38 kinase inhibitors
WO2000010563A1 (en) 1998-08-20 2000-03-02 Smithkline Beecham Corporation Novel substituted triazole compounds
DE69915862T2 (de) * 1998-11-20 2004-08-05 G.D. Searle Llc Verfahren zur herstellung 5-substituierter pyrazole unter verwendung von dithietane
US7122666B2 (en) 1999-07-21 2006-10-17 Sankyo Company, Limited Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
US6759410B1 (en) * 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
US7057049B2 (en) 2001-09-25 2006-06-06 Pharmacia Corporation Process for making substituted pyrazoles
KR100697482B1 (ko) 2001-09-25 2007-03-20 파마시아 코포레이션 치환된 피라졸의 제조 방법
CA2476822A1 (en) * 2002-02-19 2003-08-28 Pharmacia Italia S.P.A. Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
JP2005538958A (ja) * 2002-06-05 2005-12-22 ファルマシア・コーポレーション p38キナーゼ阻害薬としてのピラゾール誘導体
WO2004004725A2 (en) 2002-07-09 2004-01-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
TW200413351A (en) 2002-08-21 2004-08-01 Astrazeneca Ab Chemical compounds
AU2003301226A1 (en) * 2002-12-20 2004-07-22 Pharmacia Corp Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2007021966A1 (en) * 2005-08-12 2007-02-22 Synta Pharmaceuticals Corp. Pyrazole compounds that modulate hsp90 activity
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
CA2687931C (en) * 2007-05-31 2016-05-24 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists and uses thereof
BRPI0923051B1 (pt) 2008-12-19 2022-07-19 Centrexion Therapeutics Corporation Pirimidin-4-carboxamidas cíclicas como antagonistas do receptor de ccr2 para o tratamento de inflamação, asma e copd, seu uso, formulação e combinação farmacêutica que os compreende
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
KR101530234B1 (ko) 2009-12-17 2015-06-19 베링거 인겔하임 인터내셔날 게엠베하 신규한 ccr2 수용체 길항제 및 이의 용도
EP2569298B1 (en) 2010-05-12 2015-11-25 Boehringer Ingelheim International GmbH Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP5646736B2 (ja) 2010-05-12 2014-12-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ccr2受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
WO2011144501A1 (en) 2010-05-17 2011-11-24 Boehringer Ingelheim International Gmbh Ccr2 antagonists and uses thereof
JP5636094B2 (ja) 2010-05-25 2014-12-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr2受容体アンタゴニスト
JP5721242B2 (ja) 2010-06-01 2015-05-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ccr2アンタゴニスト
EP2731941B1 (en) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Novel and selective ccr2 antagonists
BR112014008223A2 (pt) 2011-10-06 2017-04-25 Bayer Ip Gmbh heterociclilpiri (mi) dinilpirazol
WO2016184378A1 (zh) 2015-05-18 2016-11-24 沈阳中化农药化工研发有限公司 含嘧啶的取代吡唑类化合物及其制备方法和用途
CN108026087B (zh) 2015-07-02 2021-06-04 中枢疗法公司 氨基嘧啶甲酮衍生物的柠檬酸盐
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
CN111004180A (zh) * 2019-09-11 2020-04-14 浙江埃森化学有限公司 一种制备氟虫腈的方法
CN115124471B (zh) * 2021-03-24 2024-02-13 中国工程物理研究院化工材料研究所 一类具有高能和低熔点特性的吡唑环类炸药及其合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63119468A (ja) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd ピラゾ−ル誘導体の製造法
DE69915862T2 (de) 1998-11-20 2004-08-05 G.D. Searle Llc Verfahren zur herstellung 5-substituierter pyrazole unter verwendung von dithietane

Also Published As

Publication number Publication date
AU758811B2 (en) 2003-04-03
DE69915862T2 (de) 2004-08-05
EP1131318A1 (en) 2001-09-12
US6482955B2 (en) 2002-11-19
US6143892A (en) 2000-11-07
US6242612B1 (en) 2001-06-05
CA2350081A1 (en) 2000-06-02
ATE262523T1 (de) 2004-04-15
US20030135057A1 (en) 2003-07-17
NZ511594A (en) 2003-01-31
ZA200103759B (en) 2002-11-27
US6750338B2 (en) 2004-06-15
US6342608B1 (en) 2002-01-29
WO2000031072A1 (en) 2000-06-02
EP1131318B1 (en) 2004-03-24
ES2219092T3 (es) 2004-11-16
US20040220232A1 (en) 2004-11-04
IL142999A0 (en) 2002-04-21
DE69915862D1 (de) 2004-04-29
PT1131318E (pt) 2004-07-30
AU1812600A (en) 2000-06-13
US20020115868A1 (en) 2002-08-22
JP2002530404A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
DK1131318T3 (da) Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner
ID27124A (id) Penghambat kinase bisiklik
ATE292118T1 (de) Pyrazolderivative als p-38 map kinase inhibitoren
SK157899A3 (en) Substituted pyrazoles as p38 kinase inhibitors, process for their preparation and pharmaceutical compositions
ATE373649T1 (de) Substituierte pyrazole als p38-kinaseinhibitoren
ATE209206T1 (de) Heterocyclisch substituierte cyclopentanderivate.
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
DK97283A (da) Fremgangsmaade til fremstilling af derivater af 1,2,4-triaziner og -pyridiner
MXPA05013076A (es) Compuestos de isoindolina-1-ona como inhibidores de cinasa.
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
BRPI0407841A (pt) inibidores heterocìclicos de quinase
DK0966444T3 (da) Fremgangsmåde til fremstilling af pyrazolderivater
DK1025085T3 (da) Heterocycler, der er anvendelige til behandling af benign prostatisk hyperplasi, og deres mellemprodukter
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
DK1095035T3 (da) Fremgangsmåde til fremstilling af 4-(3-pyridinyl)-1H-imidazol og de anvendte mellemprodukter
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
DK1250335T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner
DK1383737T3 (da) Fremgangsmåde til fremstillingen af alkyl-N-(3-dimethylamino)alkylcabamater
DK1064857T3 (da) Fremgangsmåde til fremstilling af sammensætninger indeholdende polyaminer
DK1131273T3 (da) 1,4-Diaryl-2-fluor-1-buten-3-olforbindelser og deres anvendelse til fremstilling af 1,4-diaryl-2-fluor-1,3-butadien- og 1,4-diaryl-2-fluor-2-butenforbindelser
ECSP992945A (es) Derivados de pirazol
DK1419167T3 (da) 1-(2,5'-anhydro-lyxofuranosyl) thyminer til syntese af radiomarkerede fluor-3 doxynucleotider
DK1350794T3 (da) Fremgangsmåde til fremstilling af substans GM-95